PPARG Post-translational Modifications Regulate Bone Formation and Bone Resorption. - Wikidata - wikimedia - TriplyDB

PPARG Post-translational Modifications Regulate Bone Formation and Bone Resorption.

PPARG Post-translational Modifications Regulate Bone Formation and Bone Resorption.

http://www.wikidata.org/entity/Q37221508

about

The role of mitochondria in osteogenic, adipogenic and chondrogenic differentiation of mesenchymal stem cells.Diabetes, bone and glucose-lowering agents: basic biology.Protein Phosphatase PP5 Controls Bone Mass and the Negative Effects of Rosiglitazone on Bone through Reciprocal Regulation of PPARγ (Peroxisome Proliferator-activated Receptor γ) and RUNX2 (Runt-related Transcription Factor 2).Reciprocal regulation of PPARγ and RUNX2 activities in marrow mesenchymal stem cells: Fine balance between p38 MAPK and Protein Phosphatase 5.Unique Interactome Network Signatures for Peroxisome Proliferator-activated Receptor Gamma (PPARγ) Modulation by Functional Selective Ligands.Skeletal fragility in diabetes.Marrow Adipose Tissue: Its Origin, Function, and Regulation in Bone Remodeling and Regeneration.Functional Regulation of PPARs through Post-Translational Modifications.CMHX008, a PPARγ partial agonist, enhances insulin sensitivity with minor influences on bone loss A structural mechanism for directing corepressor-selective inverse agonism of PPARγ N-Acetylcysteine (NAC) Ameliorates Lipid-Related Metabolic Dysfunction in Bone Marrow Stromal Cells-Derived Adipocytes Chemical Crosslinking Mass Spectrometry Reveals the Conformational Landscape of the Activation Helix of PPARγ; a Model for Ligand-Dependent Antagonism Deciphering the Roles of PPARγ in Adipocytes via Dynamic Change of Transcription Complex

P2860

Q33729045-ADC09F04-9BF4-4D4F-98FE-FC0A263E0B75 Q33843692-81378483-49AA-4F68-8ED0-E30859AE70D0 Q46080639-278B569B-5269-4C49-B153-0CAC1122CF9C Q47256544-6FF326F6-EA9A-4C1E-AAD0-D4B9EB5A4628 Q47709745-16E85995-713E-415E-A92B-AEE7FEC91BB4 Q50021725-DDEBBFE5-F2BC-4803-816C-B8AF2BF824E8 Q55405123-4629D5B6-7CFD-4738-9345-5E457F88AB7A Q55644874-1DA2AB0D-1D37-41D9-9116-2BC8E9E96C69 Q57497106-99C39712-C995-4B74-9EE4-AAD85309B09F Q58586525-0C63B972-D71E-4413-A06B-1C50616D8582 Q58695435-AF8D7B34-4D73-4F14-A7ED-E8DEC3ECC56C Q58709352-23B21DB2-00DC-4495-83DB-D5C3C91EBBF7 Q58728899-BF7FC400-34AB-48A8-9643-8E725A2EAED4

P2860

PPARG Post-translational Modifications Regulate Bone Formation and Bone Resorption.

http://www.wikidata.org/entity/Q37221508

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 29 June 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

PPARG Post-translational Modifications Regulate Bone Formation and Bone Resorption.

@en

PPARG Post-translational Modifications Regulate Bone Formation and Bone Resorption.

@nl

type

label

PPARG Post-translational Modifications Regulate Bone Formation and Bone Resorption.

@en

PPARG Post-translational Modifications Regulate Bone Formation and Bone Resorption.

@nl

prefLabel

PPARG Post-translational Modifications Regulate Bone Formation and Bone Resorption.

@en

PPARG Post-translational Modifications Regulate Bone Formation and Bone Resorption.

@nl

P1433

Q37221508-BFEF3420-3D1B-45B5-9409-696BAC8BF84C

P1476

Q37221508-08CEB225-24C8-4371-BF1E-B587D247BADB

P2093

Q37221508-0BAF7386-EDD1-47BC-8F07-18EE7D3DA746

Q37221508-23C18CE7-80E0-4493-9E35-C34A67A029CC

Q37221508-4B136DF9-8E49-4FD6-9CF4-692CD9FBA97D

Q37221508-5055223F-D869-4C01-A53E-460FBB3C718A

Q37221508-6DD52E94-2080-464D-9161-3C6225AC65F7

Q37221508-7075379F-4745-4A37-ADD0-5DCF4933C566

Q37221508-9AC4BA4F-C200-4DE7-A3B5-6D37EA0840AD

Q37221508-B88DEE06-0CB1-427A-BFD1-8F8E4D5C6462

Q37221508-C67F58AF-B888-467D-A1DF-E1E32F931169

Q37221508-CAB00434-21D9-4F85-B539-B33ECD5FDE4C

P2860

Q37221508-0098C2B0-81BA-4E77-BD99-FC311BCC14D5

Q37221508-037817E2-42ED-42E1-AFB2-0A47BC11CBE9

Q37221508-0A0F0A97-A55A-4A5A-A812-A251328F63B9

Q37221508-14A10A4D-B78E-451A-87C2-D67311245ABA

Q37221508-16335ACB-EF57-49FD-8D20-BF0F4837E817

Q37221508-1A6EBB5E-2017-47C7-B051-A08075B6915F

Q37221508-1BC8201F-53A9-44D8-BEFE-6218A4F14C15

Q37221508-2128AC9A-F9CC-491A-8F36-49A14E514905

Q37221508-28F80F5D-8A37-4D58-AB40-2F6594C5E9FC

Q37221508-38362FE3-A3EC-4BCE-AA50-A7D08516679B

P304

Q37221508-20F30930-13EB-4FD5-AD34-92D508FECDF8

P31

Q37221508-09261D90-1D74-443F-BFFB-5006C579B565

P356

Q37221508-E53E74DA-2562-4EB3-BB72-90811025C848

P478

Q37221508-C29F6734-44AF-4719-96C1-ED6B7E765666

P50

Q37221508-2821CACB-3DA7-475E-A4AC-0AB143E65823

P577

Q37221508-F08A7606-F44B-43D7-A2FF-B02CA671E1C9

P698

Q37221508-C817D3B3-A64B-40DC-AADB-A2D894574DE4

P932

Q37221508-FB1CF531-8EB6-49E5-B7A4-614C4E59F0A6

P356

J.EBIOM.2016.06.040

P1433

P1476

PPARG Post-translational Modifications Regulate Bone Formation and Bone Resorption

@en

P2093

A Asteian

http://www.w3.org/2001/XMLSchema#string

B Lecka-Czernik

http://www.w3.org/2001/XMLSchema#string

C A Corzo

http://www.w3.org/2001/XMLSchema#string

C J Rosen

http://www.w3.org/2001/XMLSchema#string

D P Marciano

http://www.w3.org/2001/XMLSchema#string

F N Tausif

http://www.w3.org/2001/XMLSchema#string

J B Bruning

http://www.w3.org/2001/XMLSchema#string

J Zheng

http://www.w3.org/2001/XMLSchema#string

P J Czernik

http://www.w3.org/2001/XMLSchema#string

P R Griffin

http://www.w3.org/2001/XMLSchema#string

P2860

Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition

Partial agonist, telmisartan, maintains PPARγ serine 112 phosphorylation, and does not affect osteoblast differentiation and bone mass

Matrix-embedded cells control osteoclast formation

WNT signaling in bone homeostasis and disease: from human mutations to treatments

Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)alpha agonist fenofibrate and the PPARgamma agonist pioglitazone.

Osteocyte Wnt/beta-catenin signaling is required for normal bone homeostasis

Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism.

Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5.

β-catenin directly sequesters adipocytic and insulin sensitizing activities but not osteoblastic activity of PPARγ2 in marrow mesenchymal stem cells.

Rosiglitazone-associated fractures in type 2 diabetes: an Analysis from A Diabetes Outcome Progression Trial (ADOPT).

P304

174-184

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EBIOM.2016.06.040

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Lance A Stechschulte

P577

2016-06-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27422345

http://www.w3.org/2001/XMLSchema#string

P932

5006645

http://www.w3.org/2001/XMLSchema#string